Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1513 of 5804
-
Spinal zaps may soothe chemo nerve pain
Symptom relief Recruiting nowThis study examines how spinal cord stimulation (SCS) affects pain level and quality of life in patients experiencing chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a nerve problem and one of the potential side effects of chemotherapy that causes pain, numbness, tingl…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Ovarian cancer drug trial halted early: what happened?
Disease control TerminatedThe goal of the study is to learn whether Niraparib or Platinum-Taxane Doublet chemotherapy is better in treating participants with Homologous Recombination Deficient (HRd) Stage III/IV Ovarian Cancer (OC). This study is a sub-study of the Master protocol -OPAL (NCT03574779)
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Hormone pill may help new mothers quit smoking for good
Disease control Recruiting nowThe investigators aim to address the following specific aims: * Determine the efficacy of Prog in preventing postpartum smoking relapse and reducing smoking relapse risk factors. * Examine the effects of this maternal smoking intervention on infant health. * Examine racial and e…
Phase: PHASE4 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could soundwaves heal diabetic foot ulcers faster?
Symptom relief OngoingSummary of the problem: Diabetes has been described as the fastest growing health crisis of our time. It currently affects more than 4.5million people in the UK. The direct cost to the NHS is already over £1 billion per year. One of the commonest complications of diabetes are fo…
Phase: NA • Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New oral drug shows promise for ulcerative colitis in early trial
Disease control CompletedThis is an open-label, single arm, multicenter, Phase 2a study evaluating the efficacy, safety, and tolerability of MORF-057 in adult patients with Moderately to Severely Active Ulcerative Colitis (UC)
Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hybrid heart procedure aims to tame stubborn AFib
Disease control OngoingThe primary objective of CONVERGE PAS is to evaluate clinical outcomes (peri-procedural and long-term) in a cohort of patients treated during commercial use of the EPi-Sense® Guided Coagulation System or EPi-Sense ST™ Coagulation System to treat symptomatic long-standing persiste…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human Phase 1a/1b multicenter, open-label study designed to evaluate the safety and anti-cancer activity of NX-5948 in patients with advanced B-cell malignancies.
Phase: PHASE1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo shows promise against deadly gut infection
Disease control CompletedPrevious data have shown that integrated information from single nucleotide polymorphisms (SNPs) of the host DNA, interleukin 8 (IL-8) and the enrichment of the stool microbiome can indicate the patients with infection by Clostridioides difficile (CDI) who are at risk for unfavor…
Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a panel of experts improve lung cancer survival?
Knowledge-focused OngoingThis trial will compare Molecular Tumor Board (MTB) assisted care to usual care for patients who have newly diagnosed histologically or cytologically confirmed stage IIb-IV Non-Small Cell Lung Cancer (NSCLC) and are planning to undergo treatment for their cancer.
Phase: NA • Sponsor: Timothy Mullett • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New drug combo aims to shrink tough head and neck tumors
Disease control CompletedWith an amendment of the protocol, this study is only open to adults with head and neck cancer. Previously also adults with liver cancer joined. This is a study for people for whom previous treatment was not successful or no standard treatment exists. The purpose of this study is…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug combo shows promise in liver cancer trial
Disease control CompletedThis is a Phase 2 trial composed of an open label Lead-In followed by a Randomized Phase designed to evaluate the efficacy and safety of SRF388 in combination with atezolizumab plus bevacizumab compared to placebo (inactive substance) in combination with atezolizumab plus bevaciz…
Phase: PHASE2 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Botox shots aim to steady shaky hands in common tremor disorder
Symptom relief CompletedUpper limb essential tremor (UL ET) is a movement disorder characterized by postural and/or kinetic tremor. It can cause difficulty with everyday tasks such as writing, pouring, and eating, and patients also experience associated social embarrassment. This study will assess how s…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New coated nail aims to stop bone infections after leg fractures
Disease control Recruiting nowPrimary objective of this study is to compare fracture related infection (FRI) rates of ZNN Bactiguard Tibia to conventional uncoated titanium-alloy nails 12 months after tibia fracture fixation. The secondary objectives are confirmation of safety, performance and clinical benef…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common diabetes drug protect the brain in Huntington's?
Disease control CompletedMulticenter, randomized, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of metformin treatment at a dose of 1700 mg / day in adults with Huntington's disease. The study consists of a screening period (2 to 4 weeks), followed by a 52-week…
Phase: PHASE3 • Sponsor: Instituto de Investigacion Sanitaria La Fe • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug aims to silence painful mouth ulcers
Disease control Recruiting nowThe objective of the study is to assess the superiority of apremilast in comparison with placebo to achieve Complete Remission (CR) of oral ulcers at Week 12, in patients with severe Recurrent aphtous stomatitis resistant or intolerant to colchicine.
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart attack mystery: study probes why 1 in 5 victims have no known risks
Knowledge-focused CompletedCoronary heart disease (CHD) is the leading cause of mortality worldwide. Every year, millions of people suffer its most adverse manifestation, an acute myocardial infraction (AMI). The majority of these patients present at least one of the standard modifiable risk factors (SMuRF…
Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New DNA test could spot lung cancer in tiny nodules
Diagnosis Recruiting nowLung cancer screening is based on low dose CT scan (LDCT), a highly sensitive but poorly specific tool. Complementary specific approaches are thus strongly needed, among which cell-free DNA (cfDNA) genotyping has been proven highly specific but of low sensitivity (25 to 50% for …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
Could one radiologist be enough for lung cancer screening in women?
Diagnosis Recruiting nowThe purpose of this study is to determine whether reading of low-dose thoracic CT scans can be done by a single general radiologist who has been trained to lung cancer screening, and will evaluate the performance in comparison with double reading by experts. The study will enrol…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New device aims to ease bathroom troubles for men with enlarged prostate
Symptom relief OngoingA prospective, multicenter, blind randomized (2:1) controlled study comparing the International Prostate Symptom Score (IPSS) of the Active arm to the IPSS of the control arm at the 3 months follow-up and active arm IPSS score change from time zero to 12 months. Patients in the a…
Phase: NA • Sponsor: Butterfly Medical Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to spare thousands from painful liver biopsies
Diagnosis Recruiting nowNAFLD, closely linked to overweight and insulin resistance, has reached 25% prevalence worldwide. Advanced liver fibrosis(ALF) must be accurately diagnosed in NAFLD because it defines a subgroup of patients with impaired prognosis, and these patients need a specific management to…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC